Abstract
BackgroundContinuous subcutaneous infusions (CSCI) are commonly used to maintain symptom control once the oral route is no longer available. In 2004, there was a worldwide shortage of diamorphine and most...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
